Why We Do What We Do at T2B
|
Hi! We've been getting lots of questions about T2B lately, so we're hosting a 30-minute info session on July 15th to pull back the curtain. We'll cover:
Who should attend?Anyone curious about T2B – whether you're considering going Pro, already a member, or just want to learn more. The real talkYou don't need to use every resource we offer. Come to think of it, it'd be bonkers if you actually had enough time to be at every event we host and peruse every resource we publish. Even tapping into a fraction delivers real value. We've been around since October 2023, and while our paid memberships are still relatively new (launched in January), we're committed to consistently showing up for our community with excellence. Every single time. Tuesday, July 15th @ 1-1:30 p.m. ET
We're looking forward to connecting with you and answering any questions you have about T2B. Talk soon, Lynnea P.S. - Can't make it live? No worries – we'll make the info session recording available. |
T2B Monthly
Hi! It's taken me a little time to gather my thoughts from moderating our recent forum session, "Future-Proofing Our Value Proposition," with Jeff Lockwood (BlueRock Therapeutics), Theresa McNeely (Lifordi Immunotherapeutics), and Ritesh Patel (Doceree) that tackled something we're all feeling: the ground shifting beneath our feet. I opened with a term I'd recently discovered—"post-labor future"—describing a world where AI doesn't just assist with tasks but takes over entire jobs. It sounds...
Hi! The photo album from the Biopharma Comms Forum is ready to browse. Scroll through the gallery Thanks to Joe Sardone and Jygantic for capturing the day so well. Feel free to share any of the photos—they're for all of us. A picture tells 1,000 words (and we have 300 pictures!), but don't worry. I'll keep this short. About a tenth of our community was in Boston in person, which tells me something important. While these gatherings create real energy and connection, they're one piece of a...
Hi! In last week's Comm Convo, we set out to answer the fundamental question, How do we move beyond delivering messages to creating genuine connection across every kind of border? Elizabeth Baxter (Mayo Clinic), Amri Johnson (Inclusion Wins), and Catherine Priestley (formerly AstraZeneca) brought us deep into the realities of global science communication—the moments when perfect translations fail, when assumptions crumble, and when curiosity becomes our most valuable currency. Here are our...